TY -
GEN
AU - Goetze, Thorsten
AU - Eickhoff, Regina
AU - Pons, Miriam
AU - Kochen, Lisa
AU - Vortmeyer, Doerthe
AU - Al-Batran, Salah-Eddin
AU - Habibzade, Timursah
AU - Adler, Marius
AU - Gonzalez-Carmona, Maria A
AU - Ettrich, Thomas Jens
AU - Koehne, Claus-Henning
AU - Pink, Daniel
AU - van Boemmel, Florian
AU - Pession, Ursula
AU - Wehler, Thomas
AU - Modest, Dominik Paul
TI -
ADJUBIL: A phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in adjuvant situation for biliary tract cancer.
PB - American Society of Clinical Oncology (ASCO)
SN - 0732-183X
SN - 1527-7755
KW - Cancer Research
KW - Oncology
PY - 2024
UR - http://slubdd.de/katalog?TN_libero_mab2
ER -